Skip to main content
. 2019 Jul 22;4:4. doi: 10.1186/s41199-019-0043-2

Table 1.

Patient Characteristics

Variable Frequency (%)
Age median [range], years 57.6 [28.6–84.0]
Gender
 Male 39 (77%)
 Female 12 (23%)
Significant history of tobacco use
 Yes 34 (67%)
 No 17 (33%)
Significant history of alcohol use
 Yes 13 (25%)
 No 38 (75%)
Primary Site
 Oropharynx 22 (43%)
 Unknown Primary 7 (13%)
 Hypopharynx 4 (8%)
 Skin 4 (8%)
 Larynx 4 (8%)
 Major Salivary Gland 4 (8%)
 Sinonasal 3 (6%)
 Nasopharynx 2 (4%)
 Oral cavity 1 (2%)
Pathology
 Squamous cell carcinoma 47 (92%)
 Acinic cell carcinoma 1 (2%)
 Adenoid cystic carcinoma 1 (2%)
 Myoepithelial carcinoma 1 (2%)
 Salivary duct carcinoma 1 (2%)
T stage
 2 2 (4%)
 3 7 (14%)
 4A 36 (70%)
 4B 4 (8%)
 4C 2 (4%)
Prior neck dissection
 Yes 27 (53%)
 No 24 (47%)
Chemotherapy (initial treatment)
 Yes 36 (71%)
 No 15 (29%)
Median initial XRT dose [range], Gy 66.0 [50–72]
Type of salvage Neck Dissection
 Modified Radical Neck Dissection 36 (71%)
 Radical Neck Dissection 15 (29%)
Interstitial Brachytherapy
 Median dose [range], Gy 60 [40–62]
 Average dose ± std., Gy 57.7 ± 4.8
 Average duration [range], d 5 [3–6]
 Average dose rate [range], cGy/h 60 (36–90)

XRT, radiation therapy; Gy, Gray; mo, months;

std., standard deviation; d, days; cGy/h, centiGray per hour;† mean time to neck recurrence is calculated for 14 patients who had local regional recurrence